Communicable & Infectious Disease News
Infectious Disease Articles
Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults
The FDA issued an emergency use authorization for Merck’s molnupiravir for the treatment of mild-to-moderate COVID-19 in certain adults.
First COVID-19 OmicronVariant Case Detected in South Dakota
Today, the FDA issued an emergency use authorization for the first oral antiviral for treatment of COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds).
Today, the South Dakota Department of Health reported the first influenza death of the 2021-2022 season.
The South Dakota Department of Health is recognizing National Influenza Vaccination Week by inviting all South Dakotans (6 months or older) to get their annual flu vaccine before the week’s end.
PIERRE, S.D. – Today, following approval of the Pfizer-BioNTech® COVID-19 Vaccine for children ages 5-11 by the U.S. Food and Drug Administration (FDA), and the final recommendation from the Centers for Disease Control and Prevention (CDC), the South Dakota Department of Health released the following statement: